In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i>_NDM, <i>bla</i>_KPC, and ESBL-Producing Enterobacteriales Uropathogens

• Päätekijät: Lubna Razaq (Tekijä), Fakhur Uddin (Tekijä), Shahzad Ali (Tekijä), Shah Muhammad Abbasi (Tekijä), Muhammad Sohail (Tekijä), Nabila E. Yousif (Tekijä), Hala M. Abo-Dief (Tekijä), Zeinhom M. El-Bahy (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2023-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infe...